Join leading international researchers and clinicians for a translational conference focused on current scientific findings and novel therapeutic approaches in epithelioid sarcoma, fostering international exchange and collaboration.
Connecting oncologists, researchers, and healthcare professionals
This translational conference builds on the success of previous years, bringing together international researchers and clinicians for two intensive days of scientific discussion. The event focuses on current scientific findings and novel therapeutic approaches in epithelioid sarcoma, fostering international exchange and collaboration among experts from leading cancer research institutions worldwide.
Explore latest research findings and clinical trial results
Learn from leading oncologists and sarcoma specialists
Improve patient outcomes through evidence-based practices
Keynote Speakers
Moderators
Days
Hours/Day
Meet the moderators and keynote speakers
Keynote Speaker - Gustave Roussy Cancer Campus, France
Leading expert in sarcoma research and translational medicine, focusing on novel therapeutic approaches.
Keynote Speaker - Memorial Sloan Kettering Cancer Center, USA
Pioneer in molecular oncology and precision medicine, specializing in rare cancer research and treatment.
German Cancer Research Center (DKFZ) & Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany
Leading researcher in pediatric oncology and sarcoma biology, specializing in molecular mechanisms of cancer development.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Expert in surgical oncology and sarcoma treatment, with extensive experience in complex tumor resections.
University of Helsinki, Finland
Professor of Biological Drug Development, Head of Drug Research Program, and expert in immunovirotherapy with extensive knowledge in developing new platforms in the fight against cancer.
European Society for Medical Oncology (ESMO)
Distinguished oncologist and researcher specializing in medical oncology, with extensive experience in cancer research and clinical practice.
University of Bologna, Italy
Associate Professor of Molecular Biology with expertise in gene regulation, molecular cell biology of infectious pathogens, and phage biotechnological research for therapeutic applications.
St. Jude Children's Research Hospital, USA
Executive Vice President and Director of the Comprehensive Cancer Center, focusing on SWI/SNF complex mutations and chromatin remodeling in cancer, with extensive experience in pediatric oncology.
Children's Cancer Therapy Development Institute, Hillsboro, USA
Scientific Director and Executive Director, specializing in developing more effective, less toxic therapies for childhood cancers, with particular focus on advanced disease and sarcoma biology.
University of Turin, Italy
Post-Doctorate Researcher in the Department of Oncology at the School of Medicine, University of Turin, specializing in medical oncology research and clinical practice.
Post-doctoral Fellow - Kirsch Lab, Princess Margaret Cancer Centre, Canada
Post-doctoral Fellow using mouse models and functional genomics to investigate mechanisms and therapeutic targets of epithelioid sarcoma.
Associate Professor - University of Torino School of Medicine, Italy
Assistant Professor involved in Experimental Cell Therapy at the Istituto di Candiolo - FPO - IRCCS, specializing in innovative cell therapy approaches for cancer treatment.
Proteomics Unit - IFOM, Italy
Member of the Proteomics Unit at IFOM, contributing to cancer research through advanced proteomic analyses and mass spectrometry technologies.
Proteomics Unit - IFOM, Italy
Member of the Proteomics Unit at IFOM, specializing in proteomic technologies and mass spectrometry to support cancer research and biomarker discovery.
Hospital for Sick Children, Canada
Pediatric oncologist and researcher specializing in sarcoma treatment and clinical trials, with extensive experience in pediatric oncology and cancer research.
Center for Cellular Immunotherapies
University of Pennsylvania
Associate Director and Senior Research Investigator specializing in cellular immunotherapies and hematology-oncology research at the University of Pennsylvania.
Team Pascal Johann, Hopp Children's Cancer Center Heidelberg, Germany
Researcher specializing in epithelioid sarcomas and extracranial rhabdoid tumours, focusing on comparative analysis at the epigenetic and spatial level.
Orchestra per la vita APS, Italy & MC4 in corsa per la vita! ETS
Senior advisor of the research branch for both the associations OPV and MC4.
SMARCB1 e.V., Germany
President of SMARCB1 e.V., dedicated to cancer research for young people and advancing sarcoma research through collaborative initiatives.
Two days of intensive scientific discussion and collaboration
Conference introduction and objectives
Prof. Dr. Dr. Thomas Grünewald, Head of Dept. Translational Pediatric Sarcoma Research, German Cancer Research Center DKFZ / Hopp-Kindertumorzentrum (KiTZ) Heidelberg, Germany; Dr. Sandro Pasquali, Surgeon and Clinician Scientist at the Sarcoma Service at the Istituto Nazionale Tumori, Milan, Italy; Dr. Michael Wortmann, SMARCB1 e.V., Germany; Andrea Bolzicco, Orchestra per la Vita APS, Italy and MC4 in corsa per la vita! ETS, ItalyModerator: Sandro Pasquali
Multi-omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics
Dr. Carine Ngo, Institut Gustave Roussy, Villejuif, France
New perspectives on amino acid transporters in Epithelioid Sarcoma
Dr. Alessandra Morelli, IFOM - Istituto FIRC di Oncologia Molecolare, Milan, Italy
Networking opportunity for all participants
Moderator: Thomas Grünewald
Leveraging tumor-penetrating photo-sono-oncolytic phage nanobots for targeted Epithelioid Sarcoma precision therapy
Prof. Alberto Danielli, FaBiT - Department of Pharmacy & Biotechnology, University of Bologna, Italy
Precision cancer vaccines for Epithelioid sarcoma
Prof. Vincenzo Cerullo, ImmunoViroTherapy Lab., University of Helsinki, Finland
Networking opportunity for all participants
Moderator: Sandro Pasquali
CRISPR screen identifies oncogenic pathways and actionable therapeutic targets in epithelioid sarcoma
Dr. Ryo Miyamoto, Princess Margaret Cancer Center – Dr. David Kirsch Lab., Toronto, Canada
SMARCB1-deficient cancers: mechanisms and vulnerabilities
Dr. Charles W. M. Roberts, Director, Comprehensive Cancer Center and Executive Vice President, St. Jude Children's Research Hospital, Memphis, USA
Networking opportunity for all participants
Combining Epigenetic Therapy and T Cell Engineering: Toward More Immunogenic Cancers
Patrizia Porazzi, PhD, Associate Director and Senior Research Investigator, Ruella Laboratory, Division of Hematology and Oncology, Center for Cellular Immunotherapies, University of Pennsylvania, USA
Epithelioid Sarcomas and extracranial Rhabdoid tumours - a comparative analysis at the epigenetic and spatial level
Marlena Mucha, Team Pascal Johann, Hopp Children's Cancer Center Heidelberg, Germany
Conclusion of first day's program
Day two introduction and objectives
Prof. Dr. Dr. Thomas Grünewald, Head of Dept. Translational Pediatric Sarcoma Research, German Cancer Research Center DKFZ / Hopp-Kindertumorzentrum (KiTZ) Heidelberg, Germany; Dr. Sandro Pasquali, Surgeon and Clinician Scientist at the Sarcoma Service at the Istituto Nazionale Tumori, Milan, Italy; Dr. Michael Wortmann, SMARCB1 e.V., Germany; Andrea Bolzicco, Orchestra per la Vita APS, Italy and MC4 in corsa per la vita! ETS, ItalyModerator: Sandro Pasquali
Developmental Oncology: On the origins of epithelioid sarcomas and considerations for their rational epigenetic therapies
Dr. Alex Kentsis, Kentsis Research Group, Memorial Sloan Kettering Cancer Center, New York, USA
Exploring the immune contexture and metabolic features in epithelioid sarcoma: rationale and preliminary data
Dr. Alessandra Merlini, University of Torino, Italy
Networking opportunity for all participants
Moderator: Sandro Pasquali
Preclinical project focused on a cellular immunotherapy approach using anti-B7-H3 CAR-CIK lymphocytes against epithelioid sarcoma
Prof. Dario Sangiolo, University of Torino, Italy
Modeling SMARCB1 deficient cancers in mice
Dr. Charles Keller, Children's Cancer Therapy Development Institute, Hillsboro, USA
Networking opportunity for all participants
Moderator: Thomas Grünewald
Exploring Functional Proteomic Signatures in Epithelioid Sarcoma
Dr. Vittoria Matafora, IFOM - Istituto FIRC di Oncologia Molecolare, Milan, Italy
TBD
Dr. Anna Czarnecka, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Networking opportunity for all participants
Moderator: Thomas Grünewald
Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma
Dr. Sarah Cohen-Gogo, The Hospital for Sick Children-University of Toronto, Canada
Summary of findings and next steps
Prof. Dr. Dr. Thomas Grünewald & Dr. Sandro PasqualiConclusion of conference program
Free registration for the premier medical conference for epithelioid sarcoma
No cost to attend
No cost to attend
Get in touch with us for more information
Lukas Wortmann
Lukas.Wortmann@smarcb1.de
SMARCB1 e.V.
Froschpfad 6
51427 Bergisch Gladbach
Germany